AbbVie Inc. (ABBV): A Bull Case Theory [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
AbbVie Inc.'s share was trading at $223.01 as of January 30th. ABBV's trailing and forward P/E were 166.99 and 15.70 respectively according to Yahoo Finance. RAJ CREATIONZS / shutterstock.com AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. ABBV is strategically positioning itself to offset revenue declines following the loss of exclusivity on its blockbuster arthritis drug Humira by pursuing innovative, high-potential therapies. The company recently announced its acquisition of Capstan Therapeutics for up to $2.1 billion, gaining access to an early-stage in vivo CAR-T therapy designed to reprogram disease-causing immune cells directly inside the body using lipid nanoparticles. This approach eliminates the need for hospital-based cell manufacturing and could offer a transformative one-time treatment for patients with autoimmune diseases, potentially r
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform [Yahoo! Finance]Yahoo! Finance
- AbbVie (NYSE:ABBV) was upgraded by analysts at UBS Group AG to a "hold" rating.MarketBeat
- AbbVie sues US health agency over Botox price controls [Yahoo! Finance Canada]Yahoo! Finance Canada
- AbbVie (NYSE:ABBV) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.MarketBeat
- AbbVie (NYSE:ABBV) was given a new $230.00 price target on by analysts at UBS Group AG.MarketBeat
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 2/4/26 - Form 8-K
- 1/7/26 - Form 8-K
- 1/5/26 - Form 4
- ABBV's page on the SEC website